This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Shanghai Syncores Technologies Inc. Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Fenghao Liu
Introduction
Fenghao Liu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of brivaracetam. His innovative methods have the potential to streamline production processes and reduce costs in the pharmaceutical industry.
Latest Patents
Fenghao Liu holds a patent for a method for preparing brivaracetam and its intermediate. The patent describes a process that involves dissolving a specific compound in a solvent, followed by crystallization, filtering, and recrystallization to obtain the desired intermediate. This method simplifies the separation of effective components, eliminating the need for complex chiral chromatography, which can be costly and time-consuming. The efficiency of this method can significantly lower the production costs associated with brivaracetam.
Career Highlights
Throughout his career, Fenghao Liu has worked with prominent companies in the pharmaceutical sector. He has been associated with Zhejiang Huahai Pharmaceutical Co., Ltd. and Shanghai Syncores Technologies Inc. Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Fenghao Liu has collaborated with several professionals in his field, including Haisheng Fan and Yipeng Zhan. These collaborations have likely enhanced his research and development efforts, leading to more effective solutions in pharmaceutical manufacturing.
Conclusion
Fenghao Liu's contributions to the field of pharmaceutical chemistry, particularly through his innovative patent for brivaracetam preparation, highlight his role as a significant inventor. His work not only advances scientific knowledge but also has practical implications for the pharmaceutical industry.